-
-
STAT (February 22, 2023) Charles River suspends shipments of monkeys used in research amid federal probe
Charles River Laboratories, one of the largest clinical research organizations in the U.S., is suspending shipments of non-human primates that are widely used in pharmaceutical research after receiving a subpoena from federal authorities probing a Cambodian smuggling ring.
CBS (February 22, 2023) Federal monkey smuggling investigation now involves Wilmington’s Charles River Labs
Charles River Laboratories announced Wednesday the company has been subpoenaed in a years-long investigation by the Department of Justice that involves the smuggling of monkeys. The company broke the news during an earnings call.
Reuters (February 22, 2023) Charles River gets DoJ subpoena on Cambodian supply of lab monkeys
Charles River Laboratories (CRL.N) said on Wednesday that it had received a subpoena from the U.S. Department of Justice over an investigation into the supply of non-human primates from Cambodia, which are a part of the animal research services that the company offers to drug developers.
Genetic Engineering & Biotechnology News (February 22, 2023) Fully Human Ovarian Organoid That Supports Egg Cell Maturation Created by Laboratory Researchers
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard Medical School (HMS), and Duke University, in collaboration with Gameto, report that they have created a living, fully human ovarian organoid that supports egg cell maturation, develops follicles, and secretes sex hormones. This “ovaroid” model enables the study of human ovarian biology without the need to take tissue from patients and could enable the development of new treatments for conditions like infertility, ovarian cancer, and more, according to the researchers.
The New Yorker (February 18, 2023) The Case for Free-Range Lab Mice
A growing body of research suggests that the unnatural lives of laboratory animals can undermine science.
-
- You must be logged in to reply to this topic.